| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Department of Gynecopathology,* Institute of Pathology, and the Departments of Clinical Chemistry¶ and Internal Medicine,|| University Hospital Eppendorf, Hamburg, Germany; Endokrinologicum Hamburg,** Hamburg, Germany; the Departments of Obstetrics and Gynaecology and Pharmacology, Laboratory of Human Reproduction, Medical School, University of Crete, Heraklion, Greece; the Department of Obstetrics and Gynaecology, University of Ioannina, Ioannina, Greece; and the First Department of Pediatrics, Athens University Medical School, Athens, Greece
Abnormalities in the process of trophoblast invasion may result in abnormal placentation. Both the embryonic trophoblast and maternal decidua produce corticotropin-releasing hormone (CRH), which promotes implantation. Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1), which is expressed in extravillous trophoblasts (EVTs) of normal human placenta, may also function in tro-phoblast/endometrial interactions. We investigated whether locally produced CRH plays a role in trophoblast invasion, primarily by regulating CEACAM1 expression. We examined cultures of freshly isolated human EVTs, which express CEACAM1, and an EVT-based hybridoma cell line, which is devoid of endogenous CEACAM1. CRH inhibited EVT invasion in Matrigel invasion assays, and this effect was blocked by the CRH receptor type 1 (CRHR1)-specific antagonist antalarmin. Additionally, CRH decreased CEACAM1 expression in EVTs in a dose-dependent manner. After transfection of the hybridoma cell line with a CEACAM1 expression vector, the invasiveness of these cells was strongly enhanced. This effect was inhibited by addition of blocking monoclonal antibody against CEACAM1. Furthermore, blocking of endogenous CEACAM1 in EVTs inhibited the invasive potential of these cells. Taken together these findings suggest that CRH inhibits trophoblast invasion by decreasing the expression of CEACAM1 through CRHR1, an effect that might be involved in the pathophysiology of clinical conditions, such as preeclampsia and placenta accreta.
This article has been cited by other articles:
 |
|
 |
|
  V. Minas, U. Jeschke, S.N. Kalantaridou, D.U. Richter, T. Reimer, I. Mylonas, K. Friese, and A. Makrigiannakis Abortion is associated with increased expression of FasL in decidual leukocytes and apoptosis of extravillous trophoblasts: a role for CRH and urocortin Mol. Hum. Reprod., September 1, 2007; 13(9): 663 - 673. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Gellersen, J. Briese, M. Oberndorfer, K. Redlin, A. Samalecos, D.-U. Richter, T. Loning, H.-M. Schulte, and A.-M. Bamberger Expression of the Metastasis Suppressor KAI1 in Decidual Cells at the Human Maternal-Fetal Interface: Regulation and Functional Implications Am. J. Pathol., January 1, 2007; 170(1): 126 - 139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. VITORATOS, D. C. PAPATHEODOROU, S. N. KALANTARIDOU, and G. MASTORAKOS "Reproductive" Corticotropin-Releasing Hormone Ann. N.Y. Acad. Sci., December 1, 2006; 1092(1): 310 - 318. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E ZOUMAKIS, K. C RICE, P.W GOLD, and G. P CHROUSOS Potential Uses of Corticotropin-Releasing Hormone Antagonists Ann. N.Y. Acad. Sci., November 1, 2006; 1083(1): 239 - 251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E Zoumakis, D K Grammatopoulos, and G P Chrousos Corticotropin-releasing hormone receptor antagonists Eur. J. Endocrinol., November 1, 2006; 155(suppl_1): S85 - S91. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
